Physician profile
Mark A Testaiuti
NPI 1316919517
$1,895.09
in general payments reported to CMS, 2019-2025
33 companies · $524 in 2025
The $524 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $404 · 2020: $15.64 · 2021: $124 · 2022: $127 · 2023: $338 · 2024: $363 · 2025: $524.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,224.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,224.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Si-Bone, INC. | $189.02 | 2019-2024 | |
| Medtronic USA, INC. | $188.72 | 2019 | |
| Providence Medical Technology, INC. | $169.61 | 2025 | |
| 4web, INC. | $145.13 | 2024 | Spine Truss System |
| Zimvie INC. | $144.72 | 2023 | |
| Nevro Corp. | $141.66 | 2019-2024 | Senza |
| Clariance, INC. | $86.04 | 2021 | |
| Intrinsic Therapeutics | $82.29 | 2021-2025 | Barricaid Acd (Annular Closure Device) |
| Globus Medical, INC. | $78.41 | 2025 | Senza, Vyrsa V1 |
| Boston Scientific Corporation | $75.49 | 2025 | General - Therapies, General - Pain Management |
| Alphatec Spine, INC | $60.40 | 2022 | |
| Spr Therapeutics, INC | $48.67 | 2024-2025 | Sprint Pns System |
| Ethicon US, LLC | $45.13 | 2019-2025 | Stratafix |
| Relievant Medsystems, INC. | $42.44 | 2022-2023 | Intracept |
| International Rehabilitative Sciences, INC | $34.00 | 2023 | Rs 4i Plus Sequential Stimulator |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Foundation Fusion Solutions, LLC | $31.85 | 2025 | |
| Saluda Medical Americas, INC. | $28.55 | 2025 | Evoke |
| Misonix INC | $28.53 | 2019-2021 | |
| Painteq LLC | $28.39 | 2024 | Painteq |
| Lemaitre Vascular, INC. | $26.97 | 2024 | Anastoclip Gc 8cm (Medium) |
| Fidia Pharma USA INC. | $23.44 | 2022 | |
| Medtronic, INC. | $22.07 | 2024 | O-Arm |
| Abbott Laboratories | $19.02 | 2025 | Proclaim |
| Baxter Healthcare | $18.36 | 2019 | |
| Collegium Pharmaceutical, INC. | $17.12 | 2025 | Xtampza |
| Kuros Biosciences USA, INC | $16.16 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $16.12 | 2024 | |
| Spinal Elements, INC. | $15.46 | 2023 | |
| Convatec INC. | $15.37 | 2024 | |
| Vertos Medical, INC. | $15.26 | 2023 | Mild Device Kit |
| Integrity Implants INC. Dba Accelus | $14.61 | 2023 | |
| Depuy Synthes Sales INC. | $13.32 | 2022 | |
| Stryker Corporation | $12.76 | 2023 | Spinejack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Testaiuti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.